Firm Record
Voyant Beauty, Inc. findings history
73 findings from 9 inspection documents published by regulators. Each row below says what its date means.
Areas cited
Regulatory reporting and change controlOther quality systemEquipment and facilityStability and storageDeviation, CAPA, and investigationComplaint and recall handlingLaboratory and QC controlsComputer system validationMaterial and supplier controlLabeling and packagingQuality unit oversight
Published inspection documents
2024-06-04
Health Canada
9 findingsStability and storage · Complaint and recall handling · Deviation, CAPA, and investigation · Computer system validation · Equipment and facility · Other quality system · Regulatory reporting and change control The temperature and/or humidity control was inadequate.
2024-06-04
Health Canada
7 findingsRegulatory reporting and change control · Complaint and recall handling · Deviation, CAPA, and investigation · Other quality system · Stability and storage · Computer system validation · Equipment and facility The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.
2024-06-04
Health Canada
7 findingsOther quality system · Equipment and facility · Regulatory reporting and change control · Deviation, CAPA, and investigation · Complaint and recall handling · Stability and storage The implementation of a self-inspection program was inadequate.
2024-06-04
Health Canada
9 findingsDeviation, CAPA, and investigation · Equipment and facility · Other quality system · Complaint and recall handling · Regulatory reporting and change control · Computer system validation · Stability and storage Investigations into deviations, reports, and/or follow-up actions were inadequate.
2021-06-14
Health Canada
6 findingsStability and storage · Other quality system · Regulatory reporting and change control · Equipment and facility · Deviation, CAPA, and investigation The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.
2021-06-14
Health Canada
11 findingsStability and storage · Other quality system · Quality unit oversight · Laboratory and QC controls · Labeling and packaging · Deviation, CAPA, and investigation · Equipment and facility · Regulatory reporting and change control The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.
2021-06-14
Health Canada
6 findingsEquipment and facility · Regulatory reporting and change control · Other quality system · Deviation, CAPA, and investigation · Stability and storage The handling of raw materials, products, or packaging materials in keeping with pre-approved written procedures or instructions was inadequate. Evaluation of production processes, equipment, and/or materials was inadequate.
2021-06-14
Health Canada
9 findingsOther quality system · Equipment and facility · Deviation, CAPA, and investigation · Regulatory reporting and change control · Stability and storage · Material and supplier control · Laboratory and QC controls The handling of standard operating procedures for good manufacturing practices was inadequate.
2021-06-14
Health Canada
9 findingsOther quality system · Deviation, CAPA, and investigation · Equipment and facility · Stability and storage · Regulatory reporting and change control · Laboratory and QC controls The evidence required to demonstrate compliance with finished product specifications was inadequate.
About this page
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
What is included. As of 2026-09-03, only documents that have a detail page (at least 3 findings) are listed. The company may have more documents; the full set is available in Company lookup below.
Companies are grouped by a normalised key, not the displayed name — “… Limited” and “… Ltd.” count as the same company. Translation and classification are automated and may differ in nuance from the source; the basis for judgement is always the regulator's published document.
